Publications

Tailoring immunisation programmes in a time of SARS-CoV-2: What can be learnt by comparing the findings of childhood and COVID-19 vaccine evaluation studies in an underserved population?.

Kasstan, B; Letley, L; MOUNIER-JACK, S; Klynman, N; GASKELL, KM; EGGO, RM; MARKS, M; CHANTLER, T;

2022

Public health in practice, (2022).4, 10.1016/j.puhip.2022.100287.

Maternal immunisation against Group B Streptococcus: a global analysis of health impact and cost-effectiveness.

Procter, S; Gonçalves, B; Paul, P; Chandna, J; Seedat, F; Koukounari, A; Hutubessy, R; Trotter, C; LAWN, J; JIT, M;

2022

medRxiv (2022). 10.1101/2022.07.11.22277482.

Health impact of routine measles vaccination and supplementary immunisation activities in 14 high burden countries: a DynaMICE modelling study.

AUZENBERGS, M; FU, H; Abbas, K; Procter, S; Cutts, F; JIT, M;

2022

medRxiv (2022). 10.1101/2022.07.11.22277494.

Effectiveness of case-area targeted interventions including vaccination on the control of epidemic cholera: protocol for a prospective observational study.

RATNAYAKE, R; Peyraud, N; Ciglenecki, I; Gignoux, E; Lightowler, M; Azman, AS; Gakima, P; Ouamba, JP; Sagara, JA; Ndombe, R; Mimbu, N; Ascorra, A; Epicentre and MSF CATI Working Group,; Welo, PO; Mukamba Musenga, E; Miwanda, B; Boum, Y; CHECCHI, F; EDMUNDS, WJ; Luquero, F; Porten, K; Finger, F;

2022

BMJ Open, (2022).12 7 10.1136/bmjopen-2022-061206.

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY.

OpenSAFELY Collaborative,; Green, A; Curtis, H; Hulme, W; WILLIAMSON, E; MCDONALD, H; BHASKARAN, K; RENTSCH, C; SCHULTZE, A; MacKenna, B; MAHALINGASIVAM, V; TOMLINSON, L; Walker, A; Fisher, L; Massey, J; Andrews, C; Hopcroft, L; Morton, C; Croker, R; Morley, J; Mehrkar, A; Bacon, S; Evans, D; Inglesby, P; Hickman, G; ... GOLDACRE, B.

2022

BMC medicine, (2022).20 1 10.1186/s12916-022-02422-0.

Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2.

Park, SW; Sun, K; Abbott, S; Sender, R; Bar-on, Y; Weitz, J; FUNK, S; Grenfell, B; Backer, J; Wallinga, J; Viboud, C; Dushoff, J;

2022

medRxiv (2022). 10.1101/2022.07.02.22277186.

Alumni mentors reduce the feeling of 'distance' in distance learning. News item for the Centre for Online and Distance Education, University of London.

FOSS, A;

2022

(2022).

Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.

Langan, S; McKenna, B; Kennedy, N; Mehkar, A; Rowan, A; Galloway, J; MATTHEWMAN, J; Mansfield, K; Bechman, K; Yates, M; Brown, J; SCHULTZE, A; Norton, S; Walker, A; Morton, C; Harrison, D; BHASKARAN, K; RENTSCH, C; WILLIAMSON, E; Croker, R; Bacon, S; Hickman, G; Ward, T; Davy, S; Green, A; ... Smith, C.

2022

BRITISH JOURNAL OF DERMATOLOGY, (2022).187,

Effectiveness of CoronaVac and BNT162b2 COVID-19 mass vaccination in Colombia: A population-based cohort study.

Paternina-Caicedo, A; JIT, M; Alvis-Guzmán, N; Fernández, JC; Hernández, J; Paz-Wilches, JJ; Rojas-Suarez, J; Dueñas-Castell, C; Alvis-Zakzuk, NJ; Smith, AD; Hoz-Restrepo, FD L;

2022

The Lancet Regional Health Americas, (2022).12, 10.1016/j.lana.2022.100296.

Comparing trained and untrained probabilistic ensemble forecasts of COVID-19 cases and deaths in the United States.

Ray, EL; Brooks, LC; Bien, J; Biggerstaff, M; BOSSE, NI; Bracher, J; Cramer, EY; FUNK, S; Gerding, A; Johansson, MA; Rumack, A; Wang, Y; Zorn, M; Tibshirani, RJ; Reich, NG;

2022

International Journal of Forecasting, (2022).39 3 10.1016/j.ijforecast.2022.06.005.